SABS
SAB Biotherapeutics, Inc.
$3.77
-0.13 (-3.33%)
At close · Jul 8
Market Cap
$302.80M
Shares
76,464,094
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-03-11 | Barclays 28th Annual Global Healthcare Conference | Conference |
| 2026-03-10 | SAB-142 Phase 1 Data in Adult Patients with Autoimmune T1D: Expert Perspective | Event |
| 2026-03-09 | Leerink Partners Global Healthcare Conference | Conference |
| 2026-02-25 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2026-02-11 | Guggenheim Emerging Outlook: Biotech Summit 2026 | Event |
| 2026-01-15 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-12-02 | 8th Annual Evercore Healthcare Conference | Conference |
| 2025-11-12 | Guggenheim Second Annual Healthcare Innovation Conference | Conference |
| 2025-11-10 | UBS Global Healthcare Conference | Conference |
Source: https://ir.sab.bio/